Call for Abstracts

Submission deadline:
April 3, 2023

Important Information

  • Submission deadline: April 3, 2023
  • Notification of acceptance: June 5, 2023
  • Registration: Presenters must be registered and have paid their registration fee by July 24, 2023; otherwise their abstract will be removed from the program.
  • ONLY accepted abstracts by a presenter registered to attend the Congress will be published in an online supplement of the Transplantation Journal.
  • It is the submitter’s responsibility to ensure that all co-authors approve of the abstract’s submission, publication, and potential presentation.

Please find below instructions to read before opening the submission page.

Abstract Submission Process

Choosing a Topic Category

During the submission process, you will be asked to select one topic category for your abstract. The topic category is the general theme under which the abstract will be reviewed and later assigned and published in the Congress materials (if accepted).

Abstract Structure

Abstracts must be comprised of four distinct sections:

  • Introduction: Describes previous research and the rationale for the current study
  • Method: Describes how the study was conducted
  • Results: Describes the results of the study
  • Conclusion: Summarize the study and discusses its implications

Please do not insert tables into the body of the abstracts. They will need to be uploaded into jpg, png or gif as a figure.

Abstract Guidelines

All abstracts must be submitted electronically through the Congress management system.

  • Abstracts should be submitted only in English
  • There is no fee for submission
  • The abstract text body is limited to 3,000 characters including spaces (about 400 words or more, depending on spacing). A maximum of two figures (in JPG, GIF or PNG with ideally 600 dpi) can be included. These will not count toward the word limit, nor will the information about authors, institutions and study groups. File size of 2 MB maximum for each figure. Make sure you submit your figure with no surrounding white space and the text is readable.
  • By submitting an abstract to Congress, the submitter consents to having the abstract (if accepted) published in the online supplement of the Transplantation Journal, as well as on the Congress website.
  • Only registered presenters will have their accepted abstracts published
  • It is the submitter’s responsibility to ensure that all co-authors approve of the abstract submission, publication, and potential presentation.
  • Presenters from employers of commercial interests, selected for an oral or a poster presentation, may be required to submit additional information, including the presentation slides. Presenting content featuring clinical recommendations aligned to the business interests and/or products of the employer is strictly prohibited.

Policies for Abstract Submission

Copyright Policy

Abstracts should not include libelous or defamatory content. Material presented in abstracts should not violate any copyright laws. If figures/graphics/images have been taken from sources not copyrighted by the author, it is the author’s sole responsibility to secure the rights from the copyright holder in writing to reproduce those figures/graphics/images for both worldwide print and web publication. All reproduction costs charged by the copyright holder must be borne by the author.

Encore Abstract Policy

The Congress welcomes the submission of abstracts previously presented at national, regional or international meetings in the two years preceding the congress. Encores must be documented as such at the time of submission. To be accepted, the abstract must include significant additional data from the previous presentation/s. Submission will not be permitted if a manuscript has been published.


The Congress regards plagiarism as serious professional misconduct. All abstracts are screened for plagiarism and when identified, the abstract and any other abstracts submitted by the same author will be rejected. In addition, the submitting author’s profile and award application, in the case one has been submitted, will also be cancelled.

Organ Trafficking and Tourism Ethics Compliance

To be eligible to submit an abstract, you must disclose that the author(s)/ scientist(s) have not violated any aspect of the following Ethics Statement:

  • Declaration of Istanbul (DOI) ethics' statement 
  • Research conforms with the ethical statement on human research subject, Helsinki Declaration of The World Medical Association
  • The Ethics of Xenotransplantation (Xenotransplantation 10:194-203, 2003) For research involving human subjects -The Helsinki. 
  • The Transplantation Society Ethics statement 

Abstract Review and Selection Process

Abstract Review
  • All submitted abstracts will go through blind peer-review carried out by an international committee
  • All abstracts will be reviewed by at least three international referees selected by the Scientific Program Committee
  • Abstracts which do not meet the focus of the topic selected by the authors will be reassigned at the discretion of the Review Committee
  • Abstracts will be assessed based the following criteria:
    • Interest: Is the content original/important/relevant to our field?
    • Novelty: How and to what extent are the findings likely to influence clinical or research practice, education or policy?
    • Robustness and quality of the data: Are the methods/ methodological approach clearly described?  How confident is the reviewer in the strength/trustworthiness of the data and/or conclusions/discussion presented?
    • Presentation and Clarity: The basic purpose of the research/project is clear
Format of Presentation

Abstracts may be submitted for either oral, poster, or oral/poster presentation (to be determined at the Committee’s discretion). Please note that space is very limited for oral abstract presentations.

Rule of Two

Each presenting author may present a maximum of two abstracts at the Congress: two orals or two posters or one oral and one poster. The number of submissions is however not limited. Should an author have more than two abstracts accepted, a co-author must be named as presenting author for one or more abstracts. All presenting authors must register and attend the Congress.

2023 Joint Congress Abstract Topics

  • Islet transplantation
  • Pancreas transplantation
  • Islet xenotransplantation
  • Cellular transplantation
  • Autologous cell therapies
  • Stem Cell and stem cell-derived
  • Muscle, bone and cartilage transplantation
  • Encapsulation of cellular transplants
  • Pre-clinical and clinical application of xenotransplantation and current barriers
  • Cell Biology and Regeneration
  • Organ, Tissue and Organoids manufacturing
  • Organ and tissue preservation, cryopreservation and reconditioning
  • Cell-based immune therapy for transplantation
  • Immune monitoring for rejection
  • Immunomodulation/tolerance
  • Inflammatory responses, innate and adaptive immunity
  • Metabolic monitoring after islet or pancreas transplantation
  • Enabling technologies (gene editing, 3D printing, imaging, extracellular vesicles)
  • Donor genetic modification for xenotransplantation
  • Ethics and regulatory requirements for clinical transplantation (moving to the clinic)
  • Miscellaneous

Organized by

Supported by

Hosted by

IPITA-IXA-CTRMS Joint Congress • San Diego, CA, USA • October 26-29, 2023

Stay Updated

Congress Secretariat

c/o: The Transplantation Society
International Headquarters
740 Notre-Dame Ouest, Suite 1245
Montréal, QC, H3C 3X6, Canada

This email address is being protected from spambots. You need JavaScript enabled to view it.
Tel: +1-514-874-1717
Fax: +1-514-874-1716